UK regulator announces clearer antidepressant safety information
The MHRA plans changes to patient information following a review involving patients, families and experts.
What the record says
The October 15 announcement describes a new boxed signpost to information on suicidal thoughts and behaviours, an expected patient card, and wording on persistent sexual dysfunction for certain antidepressants. A separate supporting safety leaflet is being developed for availability in 2027.
Source details and supporting locations.
Practical next step
The MHRA advises patients to speak with their healthcare professional before stopping an antidepressant.
Limits and what is not established
The measures clarify existing risk information; they are not a medicine recall. The supporting leaflet is prospective, and individual treatment decisions require clinical advice.
Sources checked October 15, 2026. Later notices may change instructions or arrangements.